Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

L. Dienstag, Jules; R. Schiff, Eugene; L. Wright, Teresa; P. Perrillo, Robert; L. Hann, Hie-Won; Goodman, Zachary; Crowther, Lynn; D. Condreay, Lynn; Woessner, Mary; Rubin, Marc; Brown, Nathaniel

doi:10.1056/nejm199910213411702

Public

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

Published in New England Journal of Medicine • Oct 21, 1999

Authors:

Jules L. Dienstag

Eugene R. Schiff

Teresa L. Wright

Abstract

BACKGROUND AND METHODS: Although the nucleoside analogue lamivudine has shown promise in patients with chronic hepatitis B, long-term data on patients from the United States are lacking. We randomly assigned previously untreated patients with chronic hepatitis B to receive either 100 mg of oral lami...

Subject

Lamivudine

Medicine

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!